Literature DB >> 28879420

Estimated incidence of high altitude retinal hemorrhages.

Gabriel Willmann1,2, Andreas Schatz3,4, Florian Gekeler3,4, Maximilian Schultheiss5.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28879420     DOI： 10.1007/s00417-017-3795-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  High altitude retinal hemorrhage.

Authors:  M Wiedman
Journal:  Arch Ophthalmol       Date:  1975-06

2.  Retinal hemorrhage at high altitude.

Authors:  R Frayser; C S Houston; A C Bryan; I D Rennie; G Gray
Journal:  N Engl J Med       Date:  1970-05-21       Impact factor: 91.245

3.  Acute mountain sickness.

Authors:  I Singh; P K Khanna; M C Srivastava; M Lal; S B Roy; C S Subramanyam
Journal:  N Engl J Med       Date:  1969-01-23       Impact factor: 91.245

4.  Delayed appearance of high altitude retinal hemorrhages.

Authors:  Daniel Barthelmes; Martina M Bosch; Tobias M Merz; Benno L Petrig; Frederic Truffer; Konrad E Bloch; Timothy A Holmes; Philippe Cattin; Urs Hefti; Miriam Sellner; Florian K P Sutter; Marco Maggiorini; Klara Landau
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

5.  Quantification of optic disc edema during exposure to high altitude shows no correlation to acute mountain sickness.

Authors:  Gabriel Willmann; M Dominik Fischer; Andreas Schatz; Kai Schommer; Andre Messias; Eberhart Zrenner; Karl U Bartz-Schmidt; Florian Gekeler
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240
  5 in total
  2 in total

1.  Hypobaric hypoxia triggers pyroptosis in the retina via NLRP3 inflammasome activation.

Authors:  Xiaorong Xin; Kun Yang; Haiping Liu; Yanrong Li
Journal:  Apoptosis       Date:  2022-01-27       Impact factor: 4.677

2.  Hesperidin ameliorates hypobaric hypoxia-induced retinal impairment through activation of Nrf2/HO-1 pathway and inhibition of apoptosis.

Authors:  Xiaorong Xin; Yanrong Li; Haiping Liu
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.